Endocyte Competitors and Similar CompaniesClear all
Endocyte's competitors and similar companies include Cleave Biosciences, Ikena Oncology, TScan Therapeutics and Century Therapeutics.
 Endocyte Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases. |  Cleave Biosciences Cleave Biosciences is a biopharmaceutical company that discovers and develops therapies for the treatment of cancer. |  Ikena Oncology Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment. |  TScan Therapeutics TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies. |  Century Therapeutics Century Therapeutics is a biotech company that develops therapies to treat cancer. | |
Founding Date | Founding Date 1995 | Founding Date 2010 | Founding Date 2016 | Founding Date 2018 | Founding Date 2018 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations West Lafayette, US HQ Saint Genis Pouilly, FR Indianapolis, US | Locations Burlingame, US HQ | Locations Boston, US HQ | Locations Waltham, US HQ | Locations Philadelphia, US HQ Hamilton, CA Seattle, US |
Employees | Employees 476% decrease | Employees 3 | Employees 5052% increase | Employees 7316% increase | Employees 107 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 82.5 m | Valuation ($) 251.6 m | Valuation ($) 115.2 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $70k (FY, 2017) | Revenue (est.) N/A | Revenue (est.) $800k (FY, 2025) | Revenue (est.) $10.3m (FY, 2025) | Revenue (est.) $109.2m (FY, 2025) |
Net income | Net income ($55.1m) (FY, 2017) | Net income N/A | Net income ($45.3m) (FY, 2025) | Net income ($129.8m) (FY, 2025) | Net income ($9.6m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 41m | Total funding raised $ 129m | Total funding raised $ 49m | Total funding raised $ 137.5m | Total funding raised $ 410m |
For sources of this data, please see the company profile
View Company Profiles
Cleave Biosciences
HQ
Burlingame, US
Employees
3
Cleave Biosciences is a biopharmaceutical company that discovers and develops therapies for the treatment of cancer.
View companyIkena Oncology
HQ
Boston, US
Employees
50
Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment.
View companyTScan Therapeutics
HQ
Waltham, US
Employees
73↑ 16% increase
TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.
View companyCentury Therapeutics
HQ
Philadelphia, US
Employees
107
Century Therapeutics is a biotech company that develops therapies to treat cancer.
View company